Ning Peng, Huang Jiali, Ouyang Hong, Feng Qiu, Cao Hongyi, Yang Fan, Hou Jie
Department of Endocrine and Metabolism, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Afliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), Geriatric Diseases Institute of Chengdu/Cancer Prevention and Treatment Institute of Chengdu, Chengdu, Sichuang 611137, PR China.
Department of Endocrine and Metabolism, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Afliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), Geriatric Diseases Institute of Chengdu/Cancer Prevention and Treatment Institute of Chengdu, Chengdu, Sichuang 611137, PR China.
Am J Med Sci. 2025 Jul;370(1):74-82. doi: 10.1016/j.amjms.2025.04.014. Epub 2025 Apr 29.
OBJECTIVE: The mortality risk among patients with diabetes is increasingly severe, yet the relationship between obesity and mortality risk in these patients remains controversial. This study evaluated the Conicity index (C-index), an indicator of abdominal obesity, to determine its value in predicting cardiovascular disease (CVD) and all-cause mortality in patients with diabetes. METHODS: This cross-sectional study utilized NHANES 1999-2018 data. Patients were grouped into quartiles based on the C-index. The relationship between the C-index and mortality risk was assessed using Cox proportional hazards regression models and restricted cubic spline (RCS) analysis. RESULTS: A total of 7694 patients with diabetes were included in the study. The obesity rate was 55.7 %, with an average follow-up duration of 88 months. During this period, 588 CVD deaths and 2094 all-cause deaths occurred. Higher C-index quartiles were associated with increased mortality risks, with hazard ratios for all-cause mortality ranging from 1.00 to 2.29 and for CVD mortality from 1.00 to 2.23. Unadjusted RCS analysis showed a linear positive correlation between the C-index and mortality risks. After adjusting for confounding factors, a non-linear positive correlation was observed between the C-index and all-cause mortality risk, particularly when the C-index exceeded 1.40. Subgroup analysis revealed that the relationship between the C-index and all-cause mortality was more significant in men and nonobese patients. CONCLUSIONS: The C-index is a valuable predictor of mortality in patients with diabetes. A C-index above 1.40, being male, and being nonobese are associated with a more significant risk of all-cause mortality.
目的:糖尿病患者的死亡风险日益严峻,然而肥胖与这些患者死亡风险之间的关系仍存在争议。本研究评估了作为腹部肥胖指标的圆锥指数(C指数),以确定其在预测糖尿病患者心血管疾病(CVD)和全因死亡率方面的价值。 方法:这项横断面研究使用了1999 - 2018年美国国家健康与营养检查调查(NHANES)的数据。患者根据C指数被分为四分位数组。使用Cox比例风险回归模型和受限立方样条(RCS)分析评估C指数与死亡风险之间的关系。 结果:本研究共纳入7694例糖尿病患者。肥胖率为55.7%,平均随访时间为88个月。在此期间,发生了588例CVD死亡和2094例全因死亡。较高的C指数四分位数与死亡风险增加相关,全因死亡率的风险比范围为1.00至2.29,CVD死亡率的风险比范围为1.00至2.23。未调整的RCS分析显示C指数与死亡风险之间呈线性正相关。在调整混杂因素后,观察到C指数与全因死亡风险之间呈非线性正相关,特别是当C指数超过1.40时。亚组分析显示,C指数与全因死亡率之间的关系在男性和非肥胖患者中更为显著。 结论:C指数是糖尿病患者死亡率的一个有价值的预测指标。C指数高于1.40、男性以及非肥胖与全因死亡风险更高相关。
Cochrane Database Syst Rev. 2022-2-24
Cochrane Database Syst Rev. 2025-5-6
Cochrane Database Syst Rev. 2021-4-19
Cochrane Database Syst Rev. 2022-8-8
Cochrane Database Syst Rev. 2017-12-22